IMF to Host Educational Patient and Family Seminar in Chicago, IL
Mark your calendar to attend the IMF's upcoming Chicago Patient and Family Seminar, August 16th and 17th. Patient & Family Seminars are the best way to stay abreast of the latest developments in the treatment and management of myeloma, while meeting and interacting with fellow myeloma patients and their families.
IMF to Host its First-Ever Multiple Myeloma Awareness Week
The IMF is pleased to announce the first-ever, Multiple Myeloma Awareness Week, August 26th - September 1st. Learn how you can become involved!
Become a Part of the IMF's Multiple Myeloma Quilt of Courage
The IMF's Multiple Myeloma Quilt of Courage is a creative project designed to celebrate the lives of those affected by multiple myeloma. For a minimum donation of $25, you will receive a 12x12 inch cotton fabric square to decorate in any manner that you choose (sewing, iron-on design, fabric paint, etc.). Fabric squares can be customized in honor of a loved one currently battling myeloma, or in memory of a loved ones courageous fight against the disease. Only 100 squares will be offered in 2002. The decorated squares will be crafted into a series of quilts that will become a travelling display at future IMF meetings and events. Click here to learn how you can become a part of this very special project.
Items of Interest:
Assessing a Decade of Progress in Cancer Control
June 2002, The Oncologist
Human Subjects Protection Legislation Likely to be Introduced in the Senate
June 2002, The Oncologist
Millennium Initiates Pivotal Phase III Clinical Trial Comparing Velcade™ (bortezomib) for Injection with High-Dose Dexamethasone in Patients with Multiple Myeloma (Company Press Release)
Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells.
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.
Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma.
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Nontraditional cytotoxic therapies for relapsed/refractory multiple myeloma.
Help Us Help Others...
As a non-profit organization, the IMF is completely dependent on the support of our members. Please consider showing your support by making a tax-deductible donation today. Donations in honor of a friend or family member make great gifts and are a wonderful way to celebrate a special occasion. You can donate online or by calling the IMF at (800) 452-CURE. We sincerely thank you for your support.
View Back Issues Online...
New to the IMF Myeloma Minute? See what you've been missing by viewing previous issues online!